COMPANY DOCTOR
NT 10-Q, 1997-05-16
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: COMPANY DOCTOR, 10QSB/A, 1997-05-16
Next: COMPANY DOCTOR, 10QSB, 1997-05-16



                            UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C. 20549
                                  
                             FORM 12B-25
                                  
                     NOTIFICATION OF LATE FILING
                                  
                                  
                                  
(Check One):       Form 10-K          Form 20-F  Form 11-K  Form 10-Q
Form N-SAR

     For Period Ended:         March 31, 1997
     {   } Transition Report on Form 10-K
     {   } Transition Report on Form 20-F
     {   } Transition Report on Form 11-K
     {   } Transition Report on Form 10-Q
     {   } Transition Report on Form N-SAR
     For the Transition Period Ended:



If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:



PART I - REGISTRANT INFORMATION


The Company Doctor
Full Name if Applicable


Former Name if Applicable

              5215 North O'Connor Blvd., Suite 1800
Address of Principal Executive Office (Street and Number)

              Irving, Texas  75039
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If  the subject report could not be filed without unreasonable effort
or  expense  and the registrant seeks relief pursuant  to  Rule  12b-
25(b),   the   following  should  be  completed.    (Check   box   if
appropriate).

          (a)  The reasons described in reasonable detail in Part III
          of  this  form could not be eliminated without unreasonable
          effort or expense;
          (b)    The   subject  annual  report,  semi-annual  report,
          transition report on Form 10-K, Form 20-F, 11-K or  Form  N
X         SAR,  or  portion thereof, will be filed on or  before  the
          fifteenth  calendar day following the prescribed due  date;
          or  the  subject quarterly report of transition  report  on
          Form  10-Q, or portion thereof will be filed on  or  before
          the  fifth calendar day following the prescribed due  date;
          and
          (c)   The  accountants' statement or other exhibit required
          by Rule 12b-25(c) has been attached if applicable.


PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-
K,  10-Q,  N SAR, or the transition report or portion thereof,  could
not be filed within the prescribed time period.

     See attached
                                     (Attach Extra Sheets if Needed)
                                                     SEC 1344 (6/94)
 PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
notification

  Shaun  P.  Mahoney                      972 401-8300
             (Name)           (Area Code)(Telephone Number)

(2)  Have  all  other periodic reports required under Section  13  or
     15(d)  of the Securities Exchange Act of 1934 or Section  30  of
     the  Investment  Company  Act of 1940 during  the  preceding  12
     months  or  for  such  shorter period that  the  registrant  was
     required  to file such report(s) been filed?  If answer  is  no,
     identify report(s)  .                      X   Yes      No



(3)  It  is  anticipated that any significant change  in  results  of
     operations  from  the corresponding period for the  last  fiscal
     year  will be reflected by the earnings statement to be included
     in the subject report to portion thereof?            Yes  X   No


     If  so,  attach an explanation of the anticipated  change,  both
     narratively and quantitatively, and, if appropriate,  state  the
     reasons why a reasonable estimate of the results cannot be made.



                               The Company Doctor
            (Name of Registrant as Specified in Charter)

has  caused  this  notification to be signed on  its  behalf  by  the
undersigned hereunto duly authorized.


Date May 16, 1997                            By:/s/ Shaun P. Mahoney

INSTRUCTION   The form may be signed by an executive officer  of  the
registrant or by any other duly authorized representative.  The  name
and  title  of the person signing the form shall be typed or  printed
beneath the signature.  If the statement is signed on behalf  of  the
registrant  by an authorized representative (other than an  executive
officer),  evidence  of the representative's  authority  to  sign  on
behalf of the registrant shall be filed with the form.


                              ATTENTION






                        GENERAL INSTRUCTIONS

1.    This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the
  General Rules and Regulations under the Securities Exchange Act  of
  1934.

2.    One signed original and four conformed copies of this form  and
  amendments  thereto must be completed and filed with the Securities
  and Exchange Commission, Washington, D.C. 20549, in accordance with
  Rule  0-3 of the General Rules and Regulations under the Act.   The
  information contained in or filed with the form will be made a matter
  of public record in the Commission files.

3.    A manually signed copy of the form and amendments thereto shall
  be filed with each national securities exchange on which any class of
  securities of the registrant is registered.

4.    Amendments to the notifications must also be filed on form 12b-
  25  but  need  not  restate  information that  has  been  correctly
  furnished.   The  form shall be clearly identified  as  an  amended
  notification.

5.    Electronic  Filers.  This form shall not be used by  electronic
  filers  unable  to  timely file a report solely due  to  electronic
  difficulties.   Filers unable to submit a report  within  the  time
  period  prescribed due to difficulties in electronic filing  should
  comply  with either Rule 201 or Rule 202 of Regulation S-T (232.201
  or  232.202 of this chapter) or apply for an adjustment  in  filing
  date  pursuant to Rule 13(b) of Regulation S-T (232.13(b)  of  this
  chapter).
                      Attachment to Form 12b-25










Additional time is necessary to electronically compile and  file  the
10-QSB.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission